Antisense Oligonucleotide [EPC]

11948 reported adverse events

Drugs of this class: CASIMERSEN EPLONTERSEN ETEPLIRSEN GOLODIRSEN NUSINERSEN TOFERSEN

These side effects are most commonly reported by patients taking drugs of the Antisense Oligonucleotide [EPC] class:

# Side effect Count
0 PRODUCT DOSE OMISSION ISSUE 1133
1 NO ADVERSE EVENT 825
2 HEADACHE 627
3 PYREXIA 586
4 POST LUMBAR PUNCTURE SYNDROME 524
5 PNEUMONIA 463
6 INTENTIONAL DOSE OMISSION 399
7 VOMITING 394
8 PROCEDURAL PAIN 392
9 POOR VENOUS ACCESS 389
See all common reactions for Antisense Oligonucleotide [EPC]

Drugs of the Antisense Oligonucleotide [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TRAUMATIC LUMBAR PUNCTURE 26 0.5098
1 POST LUMBAR PUNCTURE SYNDROME 524 0.5038
2 SPINAL MUSCULAR ATROPHY 107 0.3963
3 NEUROLOGICAL PROCEDURAL COMPLICATION 27 0.2045
4 CSF PRESSURE INCREASED 23 0.0865
5 PROCEDURAL VOMITING 48 0.0738
6 PROCEDURAL NAUSEA 45 0.0559
7 PROCEDURAL HEADACHE 21 0.0512
8 PROCEDURAL ANXIETY 30 0.0442
9 CEREBROSPINAL FLUID LEAKAGE 79 0.0427
See all enriched reactions for Antisense Oligonucleotide [EPC]